Eiji Kajiwara

Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection

Kentaro Matsuura, Hiromi Sawai, Kazuho Ikeo et al. · Gastroenterology · 2017 · 138 citations

Life Sciences, Genetics, Molecular Genetics +17

Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study

Eiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara et al. · Journal of Hepatology · 2012 · 129 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Short‐term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct‐acting anti‐viral treatment

Eiichi Ogawa, Norihiro Furusyo, Hideyuki Nomura et al. · Alimentary Pharmacology & Therapeutics · 2017 · 111 citations · Full text

Medicine, Infectious Diseases, Hepatitis Pharmacotherapy +11

Factors contributing to ribavirin‐induced anemia

Hideyuki Nomura, Hironori Tanimoto, Eiji Kajiwara et al. · Journal of Gastroenterology and Hepatology · 2004 · 81 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes

Naoki Yamashita, Aritsune Ohho, Akihiro Yamasaki et al. · Journal of Gastroenterology · 2013 · 73 citations

Medicine, Oncology, Pathology +16